2025 台灣美國商會癌症創新論壇: 聚焦國家願景，強化癌症照護連續性策略
日期：2025年7月28日(一)
時間：13:00 – 17:00
地點：台北晶華酒店三樓宴會廳A+B
主辦單位：美國在台協會（AIT）／台灣美國商會（AmCham Taiwan）
活動簡介：
台灣美國商會（AmCham Taiwan）與美國在台協會（AIT）攜手舉辦2025年「台灣美國商會癌症創新論壇」，匯聚政府、產業、學界與病友團體，共同推動癌症治療創新、強化病患照護、促進國際合作，並以具體政策行動打造更完善的癌症健康照護生態系。
本次論壇亦呼應賴清德總統提出之健康台灣政策願景，目標於2030年將台灣癌症標準化死亡率降低三分之一。總統長期關注癌症議題，並致力於強化國家癌症防治策略，透過擴大篩檢、設立百億癌症新藥基金及加速創新藥物與先進治療的投資，扭轉癌症疾病趨勢，為癌症病友帶來新希望。
論壇內容將聚焦於落實癌症照護連續性目標，強調及早診療的重要性，並期盼加速健保給付接軌國際指引，針對不同癌別擬定精準策略，同時優化台灣癌症照護品質，完善癌症整體國家政策。同時也將探討以永續為核心，強化「Cancer Drugs Fund (CDF) 癌症新藥基金」之效能發揮，促進創新醫療的可近性，並回歸健保制度設計本質，以提升整體照護體系的韌性與公平性。 台灣美國商會期望台灣持續站穩癌症研究與病患照護的前線，並深化國際合作，攜手推動癌症治療的創新突破。
本次論壇將匯聚來自政府部門、產業界、學術領域與病友團體的重要代表，共同深入探討癌症照護與創新治療的未來方向，期盼透過跨界協作，讓癌症不再是無法戰勝的宿命，而是一項全民齊心努力、積極面對的挑戰，共同攜手實踐健康台灣。
※論壇以中文進行，並全程提供中翻英同步口譯服務。
AmCham 2025 Cancer Summit:
Advancing Innovation Toward National Goals to Strengthen Comprehensive Cancer Care
Date: July 28th, 2025 (Monday)
Time: 13:00 – 17:00
Venue: 3F Grand Ballroom A+B, Regent Hotel Taipei
Organizers: American Institute in Taiwan, AmCham Taiwan
Event Overview:
AmCham Taiwan and the American Institute in Taiwan (AIT) are co-hosting the 2025 Cancer Summit, bringing together government officials, industry leaders, academia, and patient groups to drive cancer treatment innovation, enhance patient care, promote international collaboration, and implement concrete policy actions to build a more comprehensive cancer healthcare ecosystem.
This summit reflects President Lai’s vision to reshape Taiwan’s cancer care landscape through the establishment of a Billion-dollar Cancer New Drugs Fund. With a longstanding focus on cancer-related issues, President Lai aims to reduce Taiwan’s cancer mortality rate by one-third by 2030 through increased investment in innovative drugs and advanced treatments—ushering in a new era of hope in the fight against cancer.
The Forum will focus on implementing a continuity-of-care strategy that emphasizes early detection and treatment. It will align Taiwan’s cancer care with international clinical guidelines, NHI reimbursement policies, and national priorities—advancing the quality of cancer care to meet developed-country benchmarks.
In addition, the Summit will explore how to maximize the impact of the Cancer Drugs Fund (CDF) by prioritizing sustainability, improving access to innovative treatments, and rethinking the design of Taiwan’s healthcare reimbursement framework to strengthen system resilience and equity.
AmCham Taiwan hopes to see Taiwan remain at the forefront of cancer research and patient care. By deepening collaboration with like-minded nations, we aim to drive breakthrough innovations in treatment.
We sincerely invite leaders from all sectors, government officials, medical experts, scholars, and patient advocates to join us in this impactful summit—where together, we aim to end cancer as we know it.
(The forum will be held in Mandarin, with simultaneous interpretation provided from Mandarin to English.)
Tentative Agenda:
Sponsors:
*Non-sponsor member companies are limited to 4 tickets total.
*Registration operates on a first-come, first-served basis. To secure your seat, payment must be completed by 12 pm on July 21.
本次活動名額有限，請盡速報名。為確保您的名額，報名費用請於7月21日，中午12點前付款。
Contact Person: Candy Chao (02) 2718-8226 ext. 235/ [email protected]
*This event is reserved for AmCham members and AmCham member companies only.
If you are a non-member and interested in attending this and future event, please contact our Membership Department: Lucy Liu (02) 2718-8226 ext. 311/ [email protected]
*Ticket Refund Policy: To cancel without penalty, written cancellation must be received by AmCham before 12 pm on July 21th (Monday), or else the full price of the event will be charged. Thank you for your understanding.
*Event Policy: Participants are strictly prohibited from engaging in any commercial activities or misconduct during the event. All attendees are expected to respect others and maintain a positive atmosphere. AmCham reserves the right to take appropriate measures if participants fail to comply.